0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Blue Eye Disease Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: September 2024
|
Report Code: QYRE-Auto-33H2969
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Blue Eye Disease Vaccines Market Insights and Forecast to 2026
BUY CHAPTERS

Blue Eye Disease Vaccines - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33H2969
Report
September 2024
Pages:105
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Blue Eye Disease Vaccines - Market Size

The global market for Blue Eye Disease Vaccines was estimated to be worth US$ 157.5 million in 2023 and is forecast to a readjusted size of US$ 212.8 million by 2030 with a CAGR of 4.3% during the forecast period 2024-2030

Blue Eye Disease Vaccines - Market

Blue Eye Disease Vaccines - Market

PoRV causes a disease commonly referred to as “blue eye disease” because of the corneal opacity seen in some affected pigs
The increasing prevalence of Blue Eye Disease, a viral infection affecting livestock, is driving the demand for vaccines. Factors such as rising awareness about animal health, government initiatives for disease control, and the growing livestock industry contribute to market expansion. Key players in the market are investing in research and development to develop effective and affordable vaccines. Additionally, advancements in biotechnology and vaccine manufacturing processes are expected to propel market growth. However, challenges such as stringent regulations and limited awareness in certain regions may hinder market growth. Overall, the Blue Eye Disease vaccines market is anticipated to witness substantial growth in the foreseeable future.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Blue Eye Disease Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Blue Eye Disease Vaccines by region & country, by Type, and by Application.
The Blue Eye Disease Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blue Eye Disease Vaccines.
Market Segmentation

Scope of Blue Eye Disease Vaccines - Market Report

Report Metric Details
Report Name Blue Eye Disease Vaccines - Market
Forecasted market size in 2030 US$ 212.8 million
CAGR 4.3%
Forecasted years 2024 - 2030
Segment by Type:
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CAHIC, Boehringer Ingelheim, MSD Animal Health, Chopper Biology, Ceva, Ringpu Biology, Qilu Animal, DHN
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Blue Eye Disease Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Blue Eye Disease Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Blue Eye Disease Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Blue Eye Disease Vaccines - Market size in 2030?

Ans: The Blue Eye Disease Vaccines - Market size in 2030 will be US$ 212.8 million.

Who are the main players in the Blue Eye Disease Vaccines - Market report?

Ans: The main players in the Blue Eye Disease Vaccines - Market are CAHIC, Boehringer Ingelheim, MSD Animal Health, Chopper Biology, Ceva, Ringpu Biology, Qilu Animal, DHN

What are the Application segmentation covered in the Blue Eye Disease Vaccines - Market report?

Ans: The Applications covered in the Blue Eye Disease Vaccines - Market report are Piglets, Adult Pigs

What are the Type segmentation covered in the Blue Eye Disease Vaccines - Market report?

Ans: The Types covered in the Blue Eye Disease Vaccines - Market report are Live Vaccines, Killed Vaccines

Recommended Reports

Animal Vaccine Markets

Porcine & Swine Health

Aquaculture & Zoonotics

1 Market Overview
1.1 Blue Eye Disease Vaccines Product Introduction
1.2 Global Blue Eye Disease Vaccines Market Size Forecast
1.2.1 Global Blue Eye Disease Vaccines Sales Value (2019-2030)
1.2.2 Global Blue Eye Disease Vaccines Sales Volume (2019-2030)
1.2.3 Global Blue Eye Disease Vaccines Sales Price (2019-2030)
1.3 Blue Eye Disease Vaccines Market Trends & Drivers
1.3.1 Blue Eye Disease Vaccines Industry Trends
1.3.2 Blue Eye Disease Vaccines Market Drivers & Opportunity
1.3.3 Blue Eye Disease Vaccines Market Challenges
1.3.4 Blue Eye Disease Vaccines Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Blue Eye Disease Vaccines Players Revenue Ranking (2023)
2.2 Global Blue Eye Disease Vaccines Revenue by Company (2019-2024)
2.3 Global Blue Eye Disease Vaccines Players Sales Volume Ranking (2023)
2.4 Global Blue Eye Disease Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Blue Eye Disease Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Blue Eye Disease Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Blue Eye Disease Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Blue Eye Disease Vaccines
2.9 Blue Eye Disease Vaccines Market Competitive Analysis
2.9.1 Blue Eye Disease Vaccines Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Blue Eye Disease Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Live Vaccines
3.1.2 Killed Vaccines
3.2 Global Blue Eye Disease Vaccines Sales Value by Type
3.2.1 Global Blue Eye Disease Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Blue Eye Disease Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Blue Eye Disease Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Blue Eye Disease Vaccines Sales Volume by Type
3.3.1 Global Blue Eye Disease Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Blue Eye Disease Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Blue Eye Disease Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Blue Eye Disease Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Piglets
4.1.2 Adult Pigs
4.2 Global Blue Eye Disease Vaccines Sales Value by Application
4.2.1 Global Blue Eye Disease Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Blue Eye Disease Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Blue Eye Disease Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Blue Eye Disease Vaccines Sales Volume by Application
4.3.1 Global Blue Eye Disease Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Blue Eye Disease Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Blue Eye Disease Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Blue Eye Disease Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Blue Eye Disease Vaccines Sales Value by Region
5.1.1 Global Blue Eye Disease Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Blue Eye Disease Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Blue Eye Disease Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Blue Eye Disease Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Blue Eye Disease Vaccines Sales Volume by Region
5.2.1 Global Blue Eye Disease Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Blue Eye Disease Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Blue Eye Disease Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Blue Eye Disease Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Blue Eye Disease Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Blue Eye Disease Vaccines Sales Value, 2019-2030
5.4.2 North America Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Blue Eye Disease Vaccines Sales Value, 2019-2030
5.5.2 Europe Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Blue Eye Disease Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Blue Eye Disease Vaccines Sales Value, 2019-2030
5.7.2 South America Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Blue Eye Disease Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Blue Eye Disease Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Blue Eye Disease Vaccines Sales Value
6.2.1 Key Countries/Regions Blue Eye Disease Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Blue Eye Disease Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Blue Eye Disease Vaccines Sales Value, 2019-2030
6.3.2 United States Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Blue Eye Disease Vaccines Sales Value, 2019-2030
6.4.2 Europe Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Blue Eye Disease Vaccines Sales Value, 2019-2030
6.5.2 China Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Blue Eye Disease Vaccines Sales Value, 2019-2030
6.6.2 Japan Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Blue Eye Disease Vaccines Sales Value, 2019-2030
6.7.2 South Korea Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Blue Eye Disease Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Blue Eye Disease Vaccines Sales Value, 2019-2030
6.9.2 India Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Blue Eye Disease Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CAHIC
7.1.1 CAHIC Company Information
7.1.2 CAHIC Introduction and Business Overview
7.1.3 CAHIC Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 CAHIC Blue Eye Disease Vaccines Product Offerings
7.1.5 CAHIC Recent Development
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Company Information
7.2.2 Boehringer Ingelheim Introduction and Business Overview
7.2.3 Boehringer Ingelheim Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Boehringer Ingelheim Blue Eye Disease Vaccines Product Offerings
7.2.5 Boehringer Ingelheim Recent Development
7.3 MSD Animal Health
7.3.1 MSD Animal Health Company Information
7.3.2 MSD Animal Health Introduction and Business Overview
7.3.3 MSD Animal Health Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 MSD Animal Health Blue Eye Disease Vaccines Product Offerings
7.3.5 MSD Animal Health Recent Development
7.4 Chopper Biology
7.4.1 Chopper Biology Company Information
7.4.2 Chopper Biology Introduction and Business Overview
7.4.3 Chopper Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Chopper Biology Blue Eye Disease Vaccines Product Offerings
7.4.5 Chopper Biology Recent Development
7.5 Ceva
7.5.1 Ceva Company Information
7.5.2 Ceva Introduction and Business Overview
7.5.3 Ceva Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Ceva Blue Eye Disease Vaccines Product Offerings
7.5.5 Ceva Recent Development
7.6 Ringpu Biology
7.6.1 Ringpu Biology Company Information
7.6.2 Ringpu Biology Introduction and Business Overview
7.6.3 Ringpu Biology Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Ringpu Biology Blue Eye Disease Vaccines Product Offerings
7.6.5 Ringpu Biology Recent Development
7.7 Qilu Animal
7.7.1 Qilu Animal Company Information
7.7.2 Qilu Animal Introduction and Business Overview
7.7.3 Qilu Animal Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qilu Animal Blue Eye Disease Vaccines Product Offerings
7.7.5 Qilu Animal Recent Development
7.8 DHN
7.8.1 DHN Company Information
7.8.2 DHN Introduction and Business Overview
7.8.3 DHN Blue Eye Disease Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 DHN Blue Eye Disease Vaccines Product Offerings
7.8.5 DHN Recent Development
8 Industry Chain Analysis
8.1 Blue Eye Disease Vaccines Industrial Chain
8.2 Blue Eye Disease Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Blue Eye Disease Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Blue Eye Disease Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Blue Eye Disease Vaccines Market Trends
    Table 2. Blue Eye Disease Vaccines Market Drivers & Opportunity
    Table 3. Blue Eye Disease Vaccines Market Challenges
    Table 4. Blue Eye Disease Vaccines Market Restraints
    Table 5. Global Blue Eye Disease Vaccines Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Blue Eye Disease Vaccines Revenue Market Share by Company (2019-2024)
    Table 7. Global Blue Eye Disease Vaccines Sales Volume by Company (2019-2024) & (M Units)
    Table 8. Global Blue Eye Disease Vaccines Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Blue Eye Disease Vaccines Price by Company (2019-2024) & (USD/K Unit)
    Table 10. Key Manufacturers Blue Eye Disease Vaccines Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Blue Eye Disease Vaccines Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Blue Eye Disease Vaccines
    Table 13. Global Blue Eye Disease Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blue Eye Disease Vaccines as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Blue Eye Disease Vaccines Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Blue Eye Disease Vaccines Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Blue Eye Disease Vaccines Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Blue Eye Disease Vaccines Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Blue Eye Disease Vaccines Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Blue Eye Disease Vaccines Sales Volume by Type: 2019 VS 2023 VS 2030 (M Units)
    Table 22. Global Blue Eye Disease Vaccines Sales Volume by Type (2019-2024) & (M Units)
    Table 23. Global Blue Eye Disease Vaccines Sales Volume by Type (2025-2030) & (M Units)
    Table 24. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Blue Eye Disease Vaccines Price by Type (2019-2024) & (USD/K Unit)
    Table 27. Global Blue Eye Disease Vaccines Price by Type (2025-2030) & (USD/K Unit)
    Table 28. Global Blue Eye Disease Vaccines Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Blue Eye Disease Vaccines Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Blue Eye Disease Vaccines Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Blue Eye Disease Vaccines Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Blue Eye Disease Vaccines Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Blue Eye Disease Vaccines Sales Volume by Application: 2019 VS 2023 VS 2030 (M Units)
    Table 34. Global Blue Eye Disease Vaccines Sales Volume by Application (2019-2024) & (M Units)
    Table 35. Global Blue Eye Disease Vaccines Sales Volume by Application (2025-2030) & (M Units)
    Table 36. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Blue Eye Disease Vaccines Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Blue Eye Disease Vaccines Price by Application (2019-2024) & (USD/K Unit)
    Table 39. Global Blue Eye Disease Vaccines Price by Application (2025-2030) & (USD/K Unit)
    Table 40. Global Blue Eye Disease Vaccines Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Blue Eye Disease Vaccines Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Blue Eye Disease Vaccines Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Blue Eye Disease Vaccines Sales Value by Region (2019-2024) & (%)
    Table 44. Global Blue Eye Disease Vaccines Sales Value by Region (2025-2030) & (%)
    Table 45. Global Blue Eye Disease Vaccines Sales Volume by Region (M Units): 2019 VS 2023 VS 2030
    Table 46. Global Blue Eye Disease Vaccines Sales Volume by Region (2019-2024) & (M Units)
    Table 47. Global Blue Eye Disease Vaccines Sales Volume by Region (2025-2030) & (M Units)
    Table 48. Global Blue Eye Disease Vaccines Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Blue Eye Disease Vaccines Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Blue Eye Disease Vaccines Average Price by Region (2019-2024) & (USD/K Unit)
    Table 51. Global Blue Eye Disease Vaccines Average Price by Region (2025-2030) & (USD/K Unit)
    Table 52. Key Countries/Regions Blue Eye Disease Vaccines Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Blue Eye Disease Vaccines Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Blue Eye Disease Vaccines Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Blue Eye Disease Vaccines Sales Volume, (2019-2024) & (M Units)
    Table 56. Key Countries/Regions Blue Eye Disease Vaccines Sales Volume, (2025-2030) & (M Units)
    Table 57. CAHIC Company Information
    Table 58. CAHIC Introduction and Business Overview
    Table 59. CAHIC Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 60. CAHIC Blue Eye Disease Vaccines Product Offerings
    Table 61. CAHIC Recent Development
    Table 62. Boehringer Ingelheim Company Information
    Table 63. Boehringer Ingelheim Introduction and Business Overview
    Table 64. Boehringer Ingelheim Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 65. Boehringer Ingelheim Blue Eye Disease Vaccines Product Offerings
    Table 66. Boehringer Ingelheim Recent Development
    Table 67. MSD Animal Health Company Information
    Table 68. MSD Animal Health Introduction and Business Overview
    Table 69. MSD Animal Health Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 70. MSD Animal Health Blue Eye Disease Vaccines Product Offerings
    Table 71. MSD Animal Health Recent Development
    Table 72. Chopper Biology Company Information
    Table 73. Chopper Biology Introduction and Business Overview
    Table 74. Chopper Biology Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 75. Chopper Biology Blue Eye Disease Vaccines Product Offerings
    Table 76. Chopper Biology Recent Development
    Table 77. Ceva Company Information
    Table 78. Ceva Introduction and Business Overview
    Table 79. Ceva Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 80. Ceva Blue Eye Disease Vaccines Product Offerings
    Table 81. Ceva Recent Development
    Table 82. Ringpu Biology Company Information
    Table 83. Ringpu Biology Introduction and Business Overview
    Table 84. Ringpu Biology Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 85. Ringpu Biology Blue Eye Disease Vaccines Product Offerings
    Table 86. Ringpu Biology Recent Development
    Table 87. Qilu Animal Company Information
    Table 88. Qilu Animal Introduction and Business Overview
    Table 89. Qilu Animal Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 90. Qilu Animal Blue Eye Disease Vaccines Product Offerings
    Table 91. Qilu Animal Recent Development
    Table 92. DHN Company Information
    Table 93. DHN Introduction and Business Overview
    Table 94. DHN Blue Eye Disease Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2019-2024)
    Table 95. DHN Blue Eye Disease Vaccines Product Offerings
    Table 96. DHN Recent Development
    Table 97. Key Raw Materials Lists
    Table 98. Raw Materials Key Suppliers Lists
    Table 99. Blue Eye Disease Vaccines Downstream Customers
    Table 100. Blue Eye Disease Vaccines Distributors List
    Table 101. Research Programs/Design for This Report
    Table 102. Key Data Information from Secondary Sources
    Table 103. Key Data Information from Primary Sources
List of Figures
    Figure 1. Blue Eye Disease Vaccines Product Picture
    Figure 2. Global Blue Eye Disease Vaccines Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Blue Eye Disease Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Blue Eye Disease Vaccines Sales Volume (2019-2030) & (M Units)
    Figure 5. Global Blue Eye Disease Vaccines Sales Price (2019-2030) & (USD/K Unit)
    Figure 6. Blue Eye Disease Vaccines Report Years Considered
    Figure 7. Global Blue Eye Disease Vaccines Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Blue Eye Disease Vaccines Players Sales Volume Ranking (2023) & (M Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Blue Eye Disease Vaccines Revenue in 2023
    Figure 10. Blue Eye Disease Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Live Vaccines Picture
    Figure 12. Killed Vaccines Picture
    Figure 13. Global Blue Eye Disease Vaccines Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Blue Eye Disease Vaccines Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Blue Eye Disease Vaccines Sales Volume by Type (2019 VS 2023 VS 2030) & (M Units)
    Figure 16. Global Blue Eye Disease Vaccines Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Blue Eye Disease Vaccines Price by Type (2019-2030) & (USD/K Unit)
    Figure 18. Product Picture of Piglets
    Figure 19. Product Picture of Adult Pigs
    Figure 20. Global Blue Eye Disease Vaccines Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 21. Global Blue Eye Disease Vaccines Sales Value Market Share by Application, 2023 & 2030
    Figure 22. Global Blue Eye Disease Vaccines Sales Volume by Application (2019 VS 2023 VS 2030) & (M Units)
    Figure 23. Global Blue Eye Disease Vaccines Sales Volume Market Share by Application, 2023 & 2030
    Figure 24. Global Blue Eye Disease Vaccines Price by Application (2019-2030) & (USD/K Unit)
    Figure 25. North America Blue Eye Disease Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 26. North America Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 27. Europe Blue Eye Disease Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 28. Europe Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 29. Asia Pacific Blue Eye Disease Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 30. Asia Pacific Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 31. South America Blue Eye Disease Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 32. South America Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 33. Middle East & Africa Blue Eye Disease Vaccines Sales Value (2019-2030) & (US$ Million)
    Figure 34. Middle East & Africa Blue Eye Disease Vaccines Sales Value by Country (%), 2023 VS 2030
    Figure 35. Key Countries/Regions Blue Eye Disease Vaccines Sales Value (%), (2019-2030)
    Figure 36. Key Countries/Regions Blue Eye Disease Vaccines Sales Volume (%), (2019-2030)
    Figure 37. United States Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 38. United States Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 39. United States Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 40. Europe Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 41. Europe Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 42. Europe Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 43. China Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 44. China Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 45. China Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 46. Japan Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 47. Japan Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 48. Japan Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 49. South Korea Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 50. South Korea Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 51. South Korea Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 52. Southeast Asia Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 53. Southeast Asia Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 54. Southeast Asia Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 55. India Blue Eye Disease Vaccines Sales Value, (2019-2030) & (US$ Million)
    Figure 56. India Blue Eye Disease Vaccines Sales Value by Type (%), 2023 VS 2030
    Figure 57. India Blue Eye Disease Vaccines Sales Value by Application (%), 2023 VS 2030
    Figure 58. Blue Eye Disease Vaccines Industrial Chain
    Figure 59. Blue Eye Disease Vaccines Manufacturing Cost Structure
    Figure 60. Channels of Distribution (Direct Sales, and Distribution)
    Figure 61. Bottom-up and Top-down Approaches for This Report
    Figure 62. Data Triangulation
    Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Novocure

SIMILAR REPORTS